(A) Progression free survival for the two groups of patients, those that had previously received 5-FU or xeloda, and those that had received at least one oxaliplatin or irinotecan containing regimen

Name: (A) Progression free survival for the two groups of patients, those that had previously received 5-FU or xeloda, and those that had received at least one oxaliplatin or irinotecan containing regimen
Creator: D Yip; M Liechtenstein; JD Shapiro; L Lim; R Dowling; P Gibbs; A Little; W Bailey; D Smith
Published: 2016-01-11 00:00:00
License: 暂无描述

Figshare2016-01-11 更新2026-04-08 收录

下载链接：

https://figshare.com/articles/dataset/(A)_Progression_free_survival_for_the_two_groups_of_patients,_those_that_had_previously_received_5-FU_or_xeloda,_and_those_that_had_received_at_least_one_oxaliplatin_or_irinotecan_containing_regimen/89451/1

下载链接

链接失效反馈

官方服务：

资源简介：

<b>Copyright information:</b>Taken from "A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy"BMC Cancer 2005;5():132-132.Published online 15 Oct 2005PMCID:PMC1274303.Copyright ï¿½ 2005 Lim et al; licensee BioMed Central Ltd. (B) Overall survival for the two groups of patients, those that had previously received 5-FU or xeloda, and those that had received at least one oxaliplatin or irinotecan containing regimen.

提供机构：

D Yip; M Liechtenstein; JD Shapiro; L Lim; R Dowling; P Gibbs; A Little; W Bailey; D Smith

创建时间：

2011-12-31